Respiratory
People with COPD across North West London will be offered daily AI support through a six-month programme involving six primary care networks. The programme begins this month, introducing Aide Health’s app across Celandine Health and MetroCare PCN, North Connect PCN, NeoHealth PCN, Regent Health PCN, St John’s Wood and Maida Vale PCN and Westminster Living [...]
A modern treatment for obstructive sleep apnoea (OSA) - described to be similar to a pacemaker - has reached its 100th implantation in the UK, marked by a milestone procedure carried out at Trafford General Hospital. The device, developed by Inspire Medical Systems Inc, is providing an additional option for patients with moderate-to-severe obstructive sleep [...]
A sleep apnoea implant is being offered in the South West as an alternative for patients unable to tolerate CPAP machines. Great Western Hospitals NHS Foundation Trust said it had become the first trust in the South West to offer the implantable device for obstructive sleep apnoea. The device is implanted inside the chest or [...]
Withings has acquired Biosency, expanding its remote monitoring capabilities for patients with respiratory insufficiency. The connected health company said the deal supports its ambition to build an independent European business serving changing healthcare systems. Founded in Rennes in 2017, Biosency has developed a modular remote monitoring system for patients with respiratory insufficiency and their caregivers. [...]
AI-powered sleep technology company Sleep Cycle has announced that more than 150,000 people have registered interest in its upcoming sleep apnea risk detection solution ahead of its commercial launch. The strong early demand underscores a significant need within sleep health and supports Sleep Cycle’s strategic expansion into medical technology and scalable digital health solutions. The [...]
The NHS has joined forces with four major pharmaceutical companies in a new programme aimed at improving care for patients with asthma and chronic obstructive pulmonary disease (COPD). The Respiratory Transformation Partnership (RTP) brings together NHS England, the Office for Life Sciences, 15 health innovation networks and AstraZeneca, Chiesi, GSK and Sanofi in a co-funded [...]
A pioneering implantable technology - often described as a ‘sleep apnoea pacemaker’ – has been introduced to the UK, offering an alternative treatment option for people living with moderate-to-severe obstructive sleep apnoea (OSA) who are unable to tolerate conventional therapies such as CPAP. Designed to prevent airway collapse during sleep, the technology works by gently [...]
Brainomix has expanded its Series C round to £18.8m to scale its AI stroke and lung imaging platforms, with a focus on accelerating deployment in the US. The company added £4.8m to fund growth of its two core products. Brainomix 360 Stroke automates imaging assessment across the acute stroke pathway to support treatment and patient [...]
Kinaset Therapeutics has raised US$103m in a Series B to move forward frevecitinib, an inhaled asthma therapy for people not controlled by standard inhalers. The Boston-based firm is developing an inhaled treatment for serious respiratory diseases. The company will use the proceeds to advance frevecitinib, an inhaled dry powder being developed for people whose asthma [...]
A genetically modified pig lung transplanted into a brain-dead patient functioned for nine days, in what researchers say is a world first. The attempt marks the first pig lung transplant into a human, after limited progress with pig kidneys and hearts. Xenotransplantation – moving organs from animals to humans – may ease organ shortages, though [...]
